DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Viracept (Nelfinavir) - Foetal Exposure During Pregnancy - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Foetal Exposure During Pregnancy (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Viracept (Nelfinavir) where reactions include foetal exposure during pregnancy. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Viracept side effects in

Reported by a physician from United States on 2012-02-21

Patient: , weighing 2.4 kg (5.3 pounds)

Reactions: Ileal Atresia, Premature Baby, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Stavudine
    Dosage: 80mgd per day
    Indication: Antiretroviral Therapy

Viracept
    Dosage: 1250mgd per day
    Indication: Antiretroviral Therapy

Epivir
    Dosage: 300mgd per day
    Indication: Antiretroviral Therapy



Possible Viracept side effects in

Reported by a physician from United States on 2012-02-06

Patient: , weighing 2.4 kg (5.3 pounds)

Reactions: Ileal Atresia, Premature Baby, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Epivir
    Dosage: 300mgd per day
    Indication: Antiretroviral Therapy

Stavudine
    Dosage: 80mgd per day
    Indication: Antiretroviral Therapy

Viracept
    Dosage: 1250mgd per day
    Indication: Antiretroviral Therapy

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017